In breast cancer, glioblastoma and salivary gland cancer cells, a CBD-mediated downregulation of Id-1, an inhibitor of basic helix-loop-helix transcription factors, has been reported as the cause of the anti-invasive effect of this compound [98–100]. Here, ID1 is linked to breast carcinoma.